Free Trial
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

Pro-Dex logo
$33.87 +0.76 (+2.30%)
Closing price 02/25/2025 04:00 PM Eastern
Extended Trading
$33.72 -0.14 (-0.43%)
As of 02/25/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pro-Dex Stock (NASDAQ:PDEX)

Key Stats

Today's Range
$31.81
$33.88
50-Day Range
$32.00
$57.78
52-Week Range
$16.39
$59.60
Volume
14,451 shs
Average Volume
29,115 shs
Market Capitalization
$110.45 million
P/E Ratio
16.85
Dividend Yield
N/A
Price Target
$52.00
Consensus Rating
Buy

Company Overview

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Pro-Dex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

PDEX MarketRank™: 

Pro-Dex scored higher than 75% of companies evaluated by MarketBeat, and ranked 255th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pro-Dex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pro-Dex has received no research coverage in the past 90 days.

  • Read more about Pro-Dex's stock forecast and price target.
  • Earnings Growth

    Earnings for Pro-Dex are expected to grow by 3.00% in the coming year, from $2.00 to $2.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pro-Dex is 16.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.68.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pro-Dex is 16.85, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.62.

  • Price to Book Value per Share Ratio

    Pro-Dex has a P/B Ratio of 3.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pro-Dex's valuation and earnings.
  • Percentage of Shares Shorted

    0.86% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pro-Dex has recently decreased by 3.24%, indicating that investor sentiment is improving.
  • Dividend Yield

    Pro-Dex does not currently pay a dividend.

  • Dividend Growth

    Pro-Dex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.86% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pro-Dex has recently decreased by 3.24%, indicating that investor sentiment is improving.
    • Insider Buying vs. Insider Selling

      In the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,239,312.00 in company stock.

    • Percentage Held by Insiders

      47.50% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 15.28% of the stock of Pro-Dex is held by institutions.

    • Read more about Pro-Dex's insider trading history.
    Receive PDEX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

    PDEX Stock News Headlines

    This Crypto Is Set to Explode in February
    It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
    Returns On Capital At Pro-Dex (NASDAQ:PDEX) Have Stalled
    See More Headlines

    PDEX Stock Analysis - Frequently Asked Questions

    Pro-Dex's stock was trading at $46.75 at the beginning of the year. Since then, PDEX shares have decreased by 27.6% and is now trading at $33.87.
    View the best growth stocks for 2025 here
    .

    Pro-Dex, Inc. (NASDAQ:PDEX) announced its quarterly earnings data on Thursday, January, 30th. The medical instruments supplier reported $0.61 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a trailing twelve-month return on equity of 21.68%.

    Pro-Dex's top institutional shareholders include Dimensional Fund Advisors LP (1.79%), Northern Trust Corp (1.10%), Geode Capital Management LLC (0.83%) and EAM Investors LLC (0.69%). Insiders that own company stock include Alisha Charlton and Angelita Rebamontan Domingo.
    View institutional ownership trends
    .

    Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL).

    Company Calendar

    Last Earnings
    1/30/2025
    Today
    2/25/2025
    Next Earnings (Estimated)
    5/01/2025
    Fiscal Year End
    6/30/2025

    Industry, Sector and Symbol

    Sector
    Medical
    Industry
    Surgical & medical instruments
    Sub-Industry
    Medical Equipment
    Current Symbol
    NASDAQ:PDEX
    Employees
    140
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $52.00
    High Stock Price Target
    $52.00
    Low Stock Price Target
    $52.00
    Potential Upside/Downside
    +57.6%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    Net Income
    $2.13 million
    Pretax Margin
    14.34%

    Debt

    Sales & Book Value

    Annual Sales
    $61.00 million
    Cash Flow
    $0.95 per share
    Book Value
    $9.76 per share

    Miscellaneous

    Free Float
    1,712,000
    Market Cap
    $107.61 million
    Optionable
    Not Optionable
    Beta
    0.53

    Social Links

    10 Best Cheap Stocks to Buy Now Cover

    MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

    Get This Free Report

    This page (NASDAQ:PDEX) was last updated on 2/26/2025 by MarketBeat.com Staff
    From Our Partners